Literature DB >> 6214798

Enzyme replacement in feline GM2 gangliosidosis: catabolic effects of human beta-hexosaminidase A.

M C Rattazzi, A M Appel, H J Baker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6214798

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN： 0361-7742


× No keyword cloud information.
  4 in total

1.  Widespread correction of central nervous system disease after intracranial gene therapy in a feline model of Sandhoff disease.

Authors:  V J McCurdy; H E Rockwell; J R Arthur; A M Bradbury; A K Johnson; A N Randle; B L Brunson; M Hwang; H L Gray-Edwards; N E Morrison; J A Johnson; H J Baker; N R Cox; T N Seyfried; M Sena-Esteves; D R Martin
Journal:  Gene Ther       Date:  2014-12-04       Impact factor: 5.250

2.  Therapeutic response in feline sandhoff disease despite immunity to intracranial gene therapy.

Authors:  Allison M Bradbury; J Nicholas Cochran; Victoria J McCurdy; Aime K Johnson; Brandon L Brunson; Heather Gray-Edwards; Stanley G Leroy; Misako Hwang; Ashley N Randle; Laura S Jackson; Nancy E Morrison; Rena C Baek; Thomas N Seyfried; Seng H Cheng; Nancy R Cox; Henry J Baker; M Begona Cachón-González; Timothy M Cox; Miguel Sena-Esteves; Douglas R Martin
Journal:  Mol Ther       Date:  2013-05-21       Impact factor: 11.454

3.  AAV-mediated gene delivery in a feline model of Sandhoff disease corrects lysosomal storage in the central nervous system.

Authors:  Hannah E Rockwell; Victoria J McCurdy; Samuel C Eaton; Diane U Wilson; Aime K Johnson; Ashley N Randle; Allison M Bradbury; Heather L Gray-Edwards; Henry J Baker; Judith A Hudson; Nancy R Cox; Miguel Sena-Esteves; Thomas N Seyfried; Douglas R Martin
Journal:  ASN Neuro       Date:  2015-04-13       Impact factor: 4.146

Review 4.  Animal models of GM2 gangliosidosis: utility and limitations.

Authors:  Cheryl A Lawson; Douglas R Martin
Journal:  Appl Clin Genet       Date:  2016-07-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.